Tieni traccia delle ultime attività di insider trading Dyne Therapeutics. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Dyne Therapeutics.
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
A Dyne Therapeutics Inc, la recente attività interna ha attirato l'attenzione. Negli ultimi 30 giorni, gli addetti ai lavori hanno riferito di aver venduto un totale di 8.10K azioni del valore di $108.04K, nel frattempo, gli addetti ai lavori hanno segnalare nessun acquisto negli ultimi 30 giorni.
Sep 09, 2025 | CEO & PRESIDENT | -2.64K | $13.41 | -$35.40K | SELL | -1.20% | 217.54K | Sep 05 | ||
Sep 08, 2025 | CHIEF COMMERCIAL OFFICER | -1.04K | $13.29 | -$13.79K | SELL | -1.08% | 94.87K | Sep 04 - Sep 05 | ||
Sep 08, 2025 | CHIEF MEDICAL OFFICER | -4.42K | $13.30 | -$58.84K | SELL | -4.77% | 88.39K | Sep 04 - Sep 05 | ||
Jul 15, 2025 | CEO & PRESIDENT | 60.00K | $9.11 | $911.00K | BUY | 37.46% | 220.18K | Jul 14 - Jul 15 | ||
Jun 06, 2025 | CEO & PRESIDENT | -4.06K | $13.35 | -$54.20K | SELL | -2.63% | 150.18K | Jun 05 | ||
Jun 06, 2025 | CHIEF MEDICAL OFFICER | -1.34K | $13.35 | -$17.92K | SELL | -1.43% | 92.81K | Jun 05 | ||
Jun 06, 2025 | CHIEF COMMERCIAL OFFICER | -146.00 | $13.35 | -$1.95K | SELL | -0.15% | 95.91K | Jun 05 | ||
Mar 13, 2025 | CHIEF COMMERCIAL OFFICER | -143.00 | $12.12 | -$1.73K | SELL | -0.15% | 96.06K | Mar 13 | ||
Mar 13, 2025 | SVP, HEAD FINANCE & ADMIN. | -1.34K | $11.38 | -$15.28K | SELL | -1.09% | 122.33K | Mar 11 | ||
Mar 13, 2025 | CHIEF SCIENTIFIC OFFICER | -2.15K | $11.38 | -$24.50K | SELL | -1.09% | 195.84K | Mar 11 | ||
Mar 07, 2025 | CHIEF MEDICAL OFFICER | -1.34K | $11.83 | -$15.89K | SELL | -1.41% | 94.16K | Mar 05 | ||
Mar 07, 2025 | CEO & PRESIDENT | -4.06K | $11.83 | -$48.04K | SELL | -2.57% | 154.24K | Mar 05 | ||
Mar 07, 2025 | SVP, HEAD FINANCE & ADMIN. | -917.00 | $11.83 | -$10.85K | SELL | -0.74% | 123.67K | Mar 05 | ||
Mar 07, 2025 | CHIEF SCIENTIFIC OFFICER | -1.09K | $11.83 | -$12.94K | SELL | -0.55% | 197.99K | Mar 05 | ||
Feb 25, 2025 | CHIEF SCIENTIFIC OFFICER | -2.60K | $13.95 | -$36.24K | SELL | -1.29% | 199.09K | Feb 18 | ||
Feb 18, 2025 | SVP, HEAD FINANCE & ADMIN. | -2.49K | $13.95 | -$34.71K | SELL | -1.96% | 124.59K | Feb 18 | ||
Dec 11, 2024 | CHIEF SCIENTIFIC OFFICER | -2.33K | $28.12 | -$65.63K | SELL | -1.14% | 201.69K | Dec 11 | ||
Dec 11, 2024 | SVP, HEAD FINANCE & ADMIN. | -1.46K | $28.12 | -$40.91K | SELL | -1.13% | 127.08K | Dec 11 | ||
Dec 10, 2024 | — | -136.11K | $29.30 | -$3.99M | SELL | -2.43% | 5.46M | Dec 06 - Dec 09 | ||
Dec 06, 2024 | — | -138.84K | $29.38 | -$4.08M | SELL | -2.42% | 5.60M | Dec 04 - Dec 05 | ||
Dec 04, 2024 | — | -110.93K | $29.50 | -$3.27M | SELL | -1.90% | 5.74M | Dec 02 - Dec 03 | ||
Nov 18, 2024 | — | 0.00 | $18.71 | -$330.66K | SELL-OPTIONS | 0.00% | 0.00 | Nov 18 | ||
Nov 18, 2024 | — | -782.00 | $33.10 | -$25.88K | SELL | -0.09% | 847.32K | Nov 14 | ||
Nov 18, 2024 | SVP, HEAD FINANCE & ADMIN. | -2.73K | $28.20 | -$77.13K | SELL | -2.77% | 95.83K | Nov 18 | ||
Nov 18, 2024 | CHIEF SCIENTIFIC OFFICER | -2.86K | $28.20 | -$80.54K | SELL | -2.03% | 137.52K | Nov 18 | ||
Nov 15, 2024 | — | -19.73K | $34.14 | -$673.75K | SELL | -0.34% | 5.79M | Nov 13 - Nov 14 | ||
Oct 22, 2024 | — | -13.54K | $35.16 | -$475.88K | SELL | -0.23% | 5.87M | Oct 18 - Oct 21 | ||
Oct 18, 2024 | — | -36.68K | $35.29 | -$1.29M | SELL | -0.62% | 5.88M | Oct 16 - Oct 17 | ||
Oct 07, 2024 | — | -5.44K | $35.13 | -$191.14K | SELL | -0.09% | 5.92M | Oct 03 | ||
Oct 03, 2024 | — | -29.94K | $35.32 | -$1.06M | SELL | -0.50% | 5.92M | Oct 01 - Oct 02 | ||
Oct 01, 2024 | — | -30.97K | $35.50 | -$1.10M | SELL | -0.52% | 5.95M | Sep 27 - Sep 30 | ||
Sep 27, 2024 | — | -3.62K | $35.14 | -$127.10K | SELL | -0.06% | 5.99M | Sep 25 - Sep 26 | ||
Sep 24, 2024 | — | -120.24K | $36.07 | -$4.34M | SELL | -1.97% | 5.99M | Sep 20 - Sep 23 | ||
Sep 20, 2024 | — | -80.29K | $36.15 | -$2.90M | SELL | -1.30% | 6.11M | Sep 18 - Sep 19 | ||
Sep 19, 2024 | CHIEF OPERATING OFFICER | -8.98K | $34.41 | -$308.86K | SELL | -6.38% | 131.64K | Sep 18 | ||
Sep 19, 2024 | SVP, HEAD FINANCE & ADMIN. | -1.39K | $34.55 | -$48.02K | SELL | -1.39% | 98.57K | Sep 18 | ||
Sep 19, 2024 | CHIEF SCIENTIFIC OFFICER | -2.34K | $34.55 | -$80.81K | SELL | -1.64% | 140.38K | Sep 18 | ||
Sep 18, 2024 | — | -4.59K | $35.10 | -$161.20K | SELL | -0.07% | 6.19M | Sep 16 - Sep 17 | ||
Sep 11, 2024 | CHIEF SCIENTIFIC OFFICER | -2.16K | $31.89 | -$68.91K | SELL | -1.49% | 142.71K | Sep 11 | ||
Sep 11, 2024 | SVP, HEAD FINANCE & ADMIN. | -1.47K | $31.89 | -$46.81K | SELL | -1.45% | 99.96K | Sep 11 | ||
Sep 11, 2024 | CHIEF OPERATING OFFICER | -5.27K | $31.89 | -$168.06K | SELL | -3.61% | 140.61K | Sep 11 | ||
Sep 10, 2024 | SVP, HEAD FINANCE & ADMIN. | -9.60K | $22.36 | -$2.59M | SELL | -8.64% | 101.43K | Sep 06 | ||
Sep 09, 2024 | — | -1.58K | $35.03 | -$55.24K | SELL | -0.03% | 6.19M | Sep 05 | ||
Sep 04, 2024 | CEO & PRESIDENT | 32.00K | $33.04 | $1.06M | BUY | ∞ | 13.00K | Sep 04 | ||
Sep 04, 2024 | — | -31.30K | $45.59 | -$1.43M | SELL | -0.50% | 6.20M | Aug 30 | ||
Aug 30, 2024 | — | -134.26K | $45.03 | -$6.05M | SELL | -2.11% | 6.23M | Aug 28 - Aug 29 | ||
Aug 28, 2024 | — | -154.90K | $44.87 | -$6.95M | SELL | -2.38% | 6.36M | Aug 26 - Aug 27 | ||
Aug 26, 2024 | — | -180.41K | $46.02 | -$8.30M | SELL | -2.69% | 6.52M | Aug 22 - Aug 23 | ||
Aug 22, 2024 | — | -222.60K | $46.61 | -$10.38M | SELL | -3.22% | 6.70M | Aug 20 - Aug 21 | ||
Aug 20, 2024 | SVP, HEAD FINANCE & ADMIN. | -2.75K | $45.12 | -$124.17K | SELL | -2.42% | 111.02K | Aug 19 | ||
Aug 20, 2024 | CHIEF BUSINESS OFFICER | -2.71K | $45.12 | -$122.05K | SELL | -2.01% | 132.11K | Aug 19 | ||
Aug 20, 2024 | CHIEF MEDICAL OFFICER | -2.32K | $45.12 | -$104.73K | SELL | -1.59% | 143.22K | Aug 19 | ||
Aug 20, 2024 | CHIEF OPERATING OFFICER | -2.91K | $45.12 | -$131.30K | SELL | -1.96% | 145.88K | Aug 19 | ||
Aug 20, 2024 | CHIEF SCIENTIFIC OFFICER | -2.64K | $45.12 | -$118.94K | SELL | -1.79% | 144.88K | Aug 19 | ||
Aug 20, 2024 | — | -248.68K | $45.48 | -$11.31M | SELL | -3.47% | 6.92M | Aug 16 - Aug 19 | ||
Aug 16, 2024 | — | -281.54K | $44.76 | -$12.60M | SELL | -3.78% | 7.17M | Aug 14 - Aug 15 | ||
Aug 14, 2024 | — | -212.48K | $42.93 | -$9.12M | SELL | -2.77% | 7.45M | Aug 12 - Aug 13 | ||
Aug 12, 2024 | — | -183.83K | $42.85 | -$7.88M | SELL | -2.34% | 7.66M | Aug 08 - Aug 09 | ||
Jun 24, 2024 | CHIEF OPERATING OFFICER | 0.00 | $20.32 | -$1.18M | SELL-OPTIONS | 0.00% | 148.79K | Jun 21 - Jun 24 | ||
Jun 13, 2024 | CHIEF OPERATING OFFICER | 0.00 | $19.45 | -$1.11M | SELL-OPTIONS | 0.00% | 148.79K | Jun 12 | ||
Jun 11, 2024 | CHIEF SCIENTIFIC OFFICER | -2.14K | $31.34 | -$66.94K | SELL | -1.43% | 147.51K | Jun 11 | ||
Jun 11, 2024 | CHIEF MEDICAL OFFICER | -2.64K | $31.27 | -$82.43K | SELL | -1.78% | 145.54K | Jun 11 | ||
Jun 11, 2024 | CHIEF OPERATING OFFICER | -5.27K | $17.92 | -$2.14M | SELL | -3.42% | 148.79K | Jun 10 - Jun 11 | ||
Jun 11, 2024 | CHIEF BUSINESS OFFICER | -1.82K | $31.34 | -$57.13K | SELL | -1.33% | 134.81K | Jun 11 | ||
Jun 11, 2024 | SVP, HEAD FINANCE & ADMIN. | -2.92K | $30.74 | -$89.78K | SELL | -2.50% | 113.77K | Jun 10 - Jun 11 | ||
May 22, 2024 | CHIEF SCIENTIFIC OFFICER | 0.00 | $16.99 | -$971.41K | SELL-OPTIONS | 0.00% | 149.65K | May 20 | ||
May 17, 2024 | CHIEF SCIENTIFIC OFFICER | -2.71K | $28.27 | -$76.47K | SELL | -1.78% | 149.65K | May 16 | ||
May 17, 2024 | CHIEF MEDICAL OFFICER | -2.38K | $28.27 | -$67.31K | SELL | -1.58% | 148.18K | May 16 | ||
May 17, 2024 | CHIEF OPERATING OFFICER | -2.74K | $28.27 | -$77.40K | SELL | -1.75% | 154.06K | May 16 | ||
May 17, 2024 | SVP, HEAD FINANCE & ADMIN. | -2.59K | $28.27 | -$73.16K | SELL | -2.17% | 116.69K | May 16 | ||
May 17, 2024 | CHIEF BUSINESS OFFICER | -2.77K | $28.27 | -$78.42K | SELL | -1.99% | 136.63K | May 16 | ||
Mar 13, 2024 | CHIEF OPERATING OFFICER | -29.49K | $26.59 | -$784.25K | SELL | -15.83% | 156.80K | Mar 08 - Mar 11 | ||
Mar 13, 2024 | CHIEF BUSINESS OFFICER | -1.78K | $15.82 | -$2.26M | SELL | -1.26% | 139.41K | Mar 08 - Mar 11 | ||
Mar 12, 2024 | CHIEF MEDICAL OFFICER | -2.62K | $25.65 | -$67.08K | SELL | -1.71% | 150.56K | Mar 11 - Mar 12 | ||
Mar 12, 2024 | SVP, HEAD FINANCE & ADMIN. | -2.67K | $15.87 | -$1.85M | SELL | -2.19% | 119.28K | Mar 08 - Mar 11 | ||
Mar 12, 2024 | CEO & PRESIDENT | -16.39K | $15.72 | -$8.84M | SELL | -2.96% | 538.00K | Mar 08 - Mar 11 | ||
Mar 12, 2024 | CHIEF SCIENTIFIC OFFICER | -2.08K | $25.70 | -$53.48K | SELL | -1.35% | 152.35K | Mar 11 | ||
Mar 11, 2024 | CEO & PRESIDENT | -9.09K | $25.85 | -$234.87K | SELL | -1.61% | 554.38K | Mar 07 | ||
Mar 11, 2024 | CHIEF SCIENTIFIC OFFICER | -2.37K | $25.85 | -$61.34K | SELL | -1.51% | 154.43K | Mar 07 | ||
Mar 11, 2024 | CHIEF OPERATING OFFICER | -1.59K | $25.85 | -$41.13K | SELL | -0.85% | 186.29K | Mar 07 | ||
Mar 11, 2024 | CHIEF MEDICAL OFFICER | -9.92K | $25.86 | -$256.58K | SELL | -6.08% | 153.18K | Mar 07 | ||
Mar 11, 2024 | CHIEF BUSINESS OFFICER | -2.43K | $25.85 | -$62.92K | SELL | -1.69% | 141.18K | Mar 07 | ||
Mar 11, 2024 | SVP, HEAD FINANCE & ADMIN. | -2.27K | $25.85 | -$58.76K | SELL | -1.83% | 121.95K | Mar 07 | ||
Mar 05, 2024 | — | -46.53K | $30.05 | -$1.40M | SELL | -0.71% | 6.55M | Mar 01 | ||
Mar 05, 2024 | 10% OWNER | -46.53K | $30.05 | -$1.40M | SELL | -5.21% | 847.39K | Mar 01 | ||
Mar 01, 2024 | CEO & PRESIDENT | 0.00 | $17.25 | -$2.34M | SELL-OPTIONS | 0.00% | 563.47K | Feb 29 - Mar 01 | ||
Mar 01, 2024 | CHIEF BUSINESS OFFICER | 0.00 | $14.59 | -$791.04K | SELL-OPTIONS | 0.00% | 143.62K | Feb 29 - Mar 01 | ||
Mar 01, 2024 | SVP, HEAD FINANCE & ADMIN. | 0.00 | $14.54 | -$344.17K | SELL-OPTIONS | 0.00% | 124.23K | Feb 29 - Mar 01 | ||
Feb 28, 2024 | — | -807.84K | $24.30 | -$19.63M | SELL | -48.31% | 864.49K | Feb 26 - Feb 28 | ||
Feb 28, 2024 | Atlas Venture Fund XI LPAtlas Venture Associates XI LPAtlas Venture Associates XI LLCAtlas Venture Opportunity Fund I LPAtlas Venture Associates Opportunity I LPAtlas Venture Associates Opportunity I LLCAtlas Venture Opportunity Fund II LPAtlas Venture Associates Opportunity II LPAtlas Venture Associates Opportunity II LLC | 10% OWNER | -807.84K | $24.30 | -$19.63M | SELL | -48.31% | 864.49K | Feb 26 - Feb 28 | |
Feb 28, 2024 | CHIEF MEDICAL OFFICER | -407.00 | $25.00 | -$10.18K | SELL | -0.25% | 163.10K | Feb 28 | ||
Feb 23, 2024 | — | -500.79K | $22.64 | -$11.34M | SELL | -35.23% | 920.84K | Feb 21 - Feb 23 | ||
Feb 23, 2024 | Atlas Venture Fund XI LPAtlas Venture Associates XI LPAtlas Venture Associates XI LLCAtlas Venture Opportunity Fund I LPAtlas Venture Associates Opportunity I LPAtlas Venture Associates Opportunity I LLCAtlas Venture Opportunity Fund II LPAtlas Venture Associates Opportunity II LPAtlas Venture Associates Opportunity II LLC | 10% OWNER | -500.79K | $22.64 | -$11.34M | SELL | -35.23% | 920.84K | Feb 21 - Feb 23 | |
Feb 20, 2024 | — | -510.15K | $23.26 | -$11.87M | SELL | -6.18% | 7.75M | Feb 15 - Feb 20 | ||
Feb 20, 2024 | 10% OWNER | -510.15K | $23.26 | -$11.87M | SELL | -6.96% | 6.82M | Feb 15 - Feb 20 | ||
Feb 14, 2024 | CHIEF MEDICAL OFFICER | -5.49K | $25.07 | -$137.71K | SELL | -3.25% | 163.50K | Feb 12 | ||
Jan 26, 2024 | CHIEF MEDICAL OFFICER | -100.00 | $25.00 | -$2.50K | SELL | -0.06% | 169.00K | Jan 26 | ||
Jan 26, 2024 | CHIEF BUSINESS OFFICER | 0.00 | $12.63 | -$475.91K | SELL-OPTIONS | 0.00% | 143.62K | Jan 26 | ||
Jan 26, 2024 | SVP, HEAD FINANCE & ADMIN. | 0.00 | $12.69 | -$303.03K | SELL-OPTIONS | 0.00% | 124.23K | Jan 26 | ||
Jan 11, 2024 | — | 1.71M | $17.50 | $30.00M | BUY | ∞ | 1.43M | Jan 09 | ||
Jan 04, 2024 | CEO & PRESIDENT | 0.00 | $11.52 | -$3.85M | SELL-OPTIONS | 0.00% | 584.97K | Jan 03 - Jan 04 | ||
Jan 04, 2024 | CHIEF SCIENTIFIC OFFICER | -19.78K | $9.80 | -$1.56M | SELL | -11.20% | 156.81K | Jan 03 - Jan 04 | ||
Jan 04, 2024 | CHIEF BUSINESS OFFICER | -11.90K | $8.66 | -$514.59K | SELL | -7.65% | 143.62K | Jan 02 - Jan 04 | ||
Jan 04, 2024 | SVP, HEAD FINANCE & ADMIN. | 0.00 | $9.92 | -$231.14K | SELL-OPTIONS | 0.00% | 124.23K | Jan 03 | ||
Dec 14, 2023 | SEE REMARKS | -2.38K | $12.02 | -$28.56K | SELL | -1.88% | 124.23K | Dec 14 | ||
Dec 12, 2023 | SEE REMARKS | -1.38K | $10.72 | -$14.79K | SELL | -1.08% | 126.60K | Dec 11 | ||
Dec 12, 2023 | CHIEF BUSINESS OFFICER | -1.25K | $10.72 | -$13.35K | SELL | -0.79% | 155.52K | Dec 11 | ||
Dec 12, 2023 | CHIEF OPERATING OFFICER | -1.62K | $10.72 | -$17.32K | SELL | -0.85% | 187.88K | Dec 11 | ||
Dec 12, 2023 | CHIEF MEDICAL OFFICER | -2.67K | $10.66 | -$28.41K | SELL | -1.55% | 169.10K | Dec 11 - Dec 12 | ||
Dec 12, 2023 | SEE REMARKS | -7.58K | $10.72 | -$81.31K | SELL | -1.28% | 584.97K | Dec 11 | ||
Dec 12, 2023 | CHIEF SCIENTIFIC OFFICER | -1.47K | $10.72 | -$15.73K | SELL | -0.82% | 176.59K | Dec 11 | ||
Dec 06, 2023 | SEE REMARKS | -2.55K | $12.01 | -$30.66K | SELL | -1.96% | 127.98K | Dec 04 - Dec 06 | ||
Nov 02, 2023 | CHIEF OPERATING OFFICER | -9.94K | $7.40 | -$73.55K | SELL | -9.51% | 94.61K | Nov 02 | ||
Sep 20, 2023 | SEE REMARKS | -1.29K | $9.41 | -$12.14K | SELL | -3.07% | 40.80K | Sep 18 | ||
Sep 20, 2023 | CHIEF BUSINESS OFFICER | -1.26K | $9.41 | -$11.87K | SELL | -2.04% | 60.60K | Sep 18 | ||
Sep 20, 2023 | CHIEF OPERATING OFFICER | -2.67K | $9.41 | -$25.14K | SELL | -2.49% | 104.54K | Sep 18 | ||
Sep 20, 2023 | SEE REMARKS | -12.03K | $9.41 | -$113.22K | SELL | -4.90% | 233.68K | Sep 18 | ||
Sep 20, 2023 | CHIEF SCIENTIFIC OFFICER | -1.44K | $9.41 | -$13.51K | SELL | -1.67% | 84.33K | Sep 18 | ||
Sep 13, 2023 | CHIEF MEDICAL OFFICER | -1.71K | $10.41 | -$17.77K | SELL | -1.88% | 89.25K | Sep 12 | ||
Sep 13, 2023 | SEE REMARKS | -1.40K | $10.41 | -$14.54K | SELL | -3.21% | 42.09K | Sep 12 | ||
Sep 13, 2023 | CHIEF BUSINESS OFFICER | -1.27K | $10.41 | -$13.18K | SELL | -2.01% | 61.87K | Sep 12 | ||
Sep 13, 2023 | CHIEF OPERATING OFFICER | -1.64K | $10.41 | -$17.02K | SELL | -1.50% | 107.22K | Sep 12 | ||
Sep 13, 2023 | SEE REMARKS | -7.67K | $10.41 | -$79.87K | SELL | -3.03% | 245.71K | Sep 12 | ||
Sep 13, 2023 | CHIEF SCIENTIFIC OFFICER | -1.48K | $10.41 | -$15.45K | SELL | -1.70% | 85.77K | Sep 12 | ||
Jun 15, 2023 | SEE REMARKS | -11.39K | $6.87 | -$611.98K | SELL | -20.76% | 43.48K | Jun 13 - Jun 15 | ||
Jun 14, 2023 | SEE REMARKS | -2.26K | $12.68 | -$28.65K | SELL | -3.45% | 63.13K | Jun 12 - Jun 13 | ||
Jun 14, 2023 | CHIEF OPERATING OFFICER | -1.63K | $12.43 | -$20.20K | SELL | -1.47% | 108.85K | Jun 13 | ||
Jun 14, 2023 | CHIEF MEDICAL OFFICER | -1.70K | $12.43 | -$21.11K | SELL | -1.83% | 90.96K | Jun 13 | ||
Jun 14, 2023 | CHIEF SCIENTIFIC OFFICER | -1.48K | $12.43 | -$18.33K | SELL | -1.66% | 87.25K | Jun 13 | ||
Jun 12, 2023 | SEE REMARKS | -69.10K | $6.96 | -$3.91M | SELL | -21.43% | 253.38K | Jun 08 - Jun 12 | ||
Mar 15, 2023 | SEE REMARKS | -1.31K | $13.33 | -$17.48K | SELL | -2.33% | 54.87K | Mar 14 | ||
Mar 15, 2023 | SEE REMARKS | -2.21K | $13.18 | -$29.12K | SELL | -3.27% | 65.39K | Mar 13 - Mar 14 | ||
Mar 15, 2023 | CHIEF OPERATING OFFICER | -1.56K | $13.33 | -$20.78K | SELL | -1.39% | 110.48K | Mar 14 | ||
Mar 15, 2023 | CHIEF MEDICAL OFFICER | -7.44K | $13.33 | -$99.19K | SELL | -7.43% | 92.66K | Mar 14 | ||
Mar 15, 2023 | SEE REMARKS | -7.32K | $13.33 | -$97.55K | SELL | -2.22% | 322.48K | Mar 14 | ||
Mar 15, 2023 | CHIEF SCIENTIFIC OFFICER | -1.42K | $13.33 | -$18.88K | SELL | -1.57% | 88.73K | Mar 14 | ||
Jan 23, 2023 | SEE REMARKS | 0.00 | $7.38 | -$133.00K | SELL-OPTIONS | 0.00% | 67.60K | Jan 18 | ||
Jan 11, 2023 | SEE REMARKS | -30.15K | $11.57 | -$348.84K | SELL | -30.84% | 67.60K | Jan 09 | ||
Dec 14, 2022 | DIRECTOR | 934.58K | $10.70 | $10.00M | BUY | 58.09% | 2.54M | Dec 12 | ||
Dec 14, 2022 | Atlas Venture Opportunity Fund II LPAtlas Venture Fund XI LPAtlas Venture Associates XI LPAtlas Venture Associates XI LLCAtlas Venture Opportunity Fund I LPAtlas Venture Associates Opportunity I LPAtlas Venture Associates Opportunity I LLCAtlas Venture Associates Opportunity II LPAtlas Venture Associates Opportunity II LLC | 10% OWNER | 934.58K | $10.70 | $10.00M | BUY | 58.09% | 2.54M | Dec 12 | |
Dec 13, 2022 | SEE REMARKS | 30.69K | $10.87 | -$3.39K | GRANT | 120.37% | 56.18K | Dec 09 - Dec 12 | ||
Dec 13, 2022 | SEE REMARKS | 39.53K | $10.87 | -$5.13K | GRANT | 67.89% | 97.75K | Dec 09 - Dec 12 | ||
Dec 13, 2022 | CHIEF OPERATING OFFICER | 43.25K | $10.87 | -$8.16K | GRANT | 62.87% | 112.03K | Dec 09 - Dec 12 | ||
Dec 13, 2022 | CHIEF MEDICAL OFFICER | 35.37K | $10.87 | -$6.83K | GRANT | 54.65% | 100.10K | Dec 09 - Dec 12 | ||
Dec 13, 2022 | SEE REMARKS | 140.68K | $10.87 | -$36.11K | GRANT | 74.38% | 329.80K | Dec 09 - Dec 12 | ||
Dec 13, 2022 | CHIEF SCIENTIFIC OFFICER | 39.32K | $10.87 | -$7.39K | GRANT | 77.36% | 90.14K | Dec 09 - Dec 12 | ||
Oct 11, 2022 | SEE REMARKS | -15.50K | $6.78 | -$2.41M | SELL | -7.57% | 189.12K | Oct 07 - Oct 10 | ||
Mar 14, 2022 | SEE REMARKS | -308.00 | $8.73 | -$2.69K | SELL | -1.13% | 26.99K | Mar 11 | ||
Mar 14, 2022 | SEE REMARKS | -481.00 | $8.73 | -$4.20K | SELL | -0.79% | 60.47K | Mar 11 | ||
Mar 14, 2022 | CHIEF OPERATING OFFICER | -765.00 | $8.73 | -$6.68K | SELL | -1.04% | 73.00K | Mar 11 | ||
Mar 14, 2022 | CHIEF MEDICAL OFFICER | -640.00 | $8.73 | -$5.59K | SELL | -0.96% | 66.05K | Mar 11 | ||
Mar 14, 2022 | SEE REMARKS | -3.38K | $8.73 | -$29.54K | SELL | -1.58% | 210.32K | Mar 11 | ||
Mar 14, 2022 | CHIEF SCIENTIFIC OFFICER | -693.00 | $8.73 | -$6.05K | SELL | -1.27% | 53.68K | Mar 11 | ||
Mar 03, 2022 | CHIEF MEDICAL OFFICER | -5.62K | $8.56 | -$48.08K | SELL | -7.77% | 66.69K | Mar 02 | ||
Sep 24, 2021 | CHIEF OPERATING OFFICER | -2.45K | $17.22 | -$42.21K | SELL | -6.83% | 33.45K | Sep 23 | ||
Sep 22, 2021 | SEE REMARKS | -859.00 | $15.90 | -$13.65K | SELL | -7.49% | 10.61K | Sep 20 - Sep 21 | ||
Sep 22, 2021 | SEE REMARKS | -1.27K | $15.90 | -$20.25K | SELL | -3.45% | 35.64K | Sep 20 - Sep 21 | ||
Sep 22, 2021 | SEE REMARKS | -8.01K | $15.90 | -$127.31K | SELL | -7.48% | 99.02K | Sep 20 - Sep 21 | ||
Sep 22, 2021 | CHIEF SCIENTIFIC OFFICER | -1.44K | $15.90 | -$22.95K | SELL | -7.49% | 17.84K | Sep 20 - Sep 21 |
Sfoglia insider trading su tutte le azioni.